A Ducoloné

2.8k total citations · 1 hit paper
30 papers, 1.5k citations indexed

About

A Ducoloné is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, A Ducoloné has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Surgery. Recurrent topics in A Ducoloné's work include Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Pulmonary Hypertension Research and Treatments (10 papers). A Ducoloné is often cited by papers focused on Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Pulmonary Hypertension Research and Treatments (10 papers). A Ducoloné collaborates with scholars based in France and Japan. A Ducoloné's co-authors include E Weitzenblum, M Ehrhart, Ari Chaouat, Romain Kessler, J Rasaholinjanahary, C. Hirth, Irina Enache, Nabila Kadaoui, Roland Schött and M Faller and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A Ducoloné

26 papers receiving 1.5k citations

Hit Papers

Prognostic value of pulmonary artery pressure in chronic ... 1981 2026 1996 2011 1981 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Ducoloné France 12 1.4k 383 249 193 160 30 1.5k
G. Simonneau France 15 1.5k 1.1× 742 1.9× 54 0.2× 161 0.8× 124 0.8× 34 1.7k
J. McGuigan United Kingdom 17 675 0.5× 124 0.3× 198 0.8× 524 2.7× 65 0.4× 54 1.1k
Hacı Mehmet Türk Türkiye 14 227 0.2× 87 0.2× 265 1.1× 163 0.8× 57 0.4× 75 708
Maria Albertsson Sweden 17 260 0.2× 132 0.3× 504 2.0× 305 1.6× 63 0.4× 35 877
Ward V. Houck United States 14 1.0k 0.7× 324 0.8× 179 0.7× 449 2.3× 55 0.3× 22 1.5k
J.-M. Bréchot France 9 298 0.2× 91 0.2× 273 1.1× 134 0.7× 146 0.9× 34 794
James Bundred United Kingdom 19 518 0.4× 111 0.3× 459 1.8× 722 3.7× 302 1.9× 42 1.2k
Simon Gibbs United Kingdom 13 1.9k 1.4× 1.2k 3.0× 52 0.2× 299 1.5× 140 0.9× 34 2.3k
Battista Fabio Viola Italy 17 414 0.3× 190 0.5× 29 0.1× 227 1.2× 262 1.6× 26 1.5k
Oh Jeong South Korea 24 1.5k 1.1× 123 0.3× 420 1.7× 891 4.6× 119 0.7× 77 1.9k

Countries citing papers authored by A Ducoloné

Since Specialization
Citations

This map shows the geographic impact of A Ducoloné's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Ducoloné with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Ducoloné more than expected).

Fields of papers citing papers by A Ducoloné

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Ducoloné. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Ducoloné. The network helps show where A Ducoloné may publish in the future.

Co-authorship network of co-authors of A Ducoloné

This figure shows the co-authorship network connecting the top 25 collaborators of A Ducoloné. A scholar is included among the top collaborators of A Ducoloné based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Ducoloné. A Ducoloné is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weitzenblum, E, Ari Chaouat, Matthieu Canuet, A Ducoloné, & Romain Kessler. (2012). Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease. PubMed. 81(4). 169–177. 14 indexed citations
2.
Mouillet, Guillaume, Élisabeth Monnet, B. Milleron, et al.. (2012). Pathologic Complete Response to Preoperative Chemotherapy Predicts Cure in Early-Stage Non–Small-Cell Lung Cancer: Combined Analysis of Two IFCT Randomized Trials. Journal of Thoracic Oncology. 7(5). 841–849. 107 indexed citations
3.
Quoix, Élisabeth, A Ducoloné, B. Mennecier, & Philippe Fraisse. (2011). Cancer bronchique non à petites cellules métastatique : les traitements systémiques des sujets de plus de 70ans. La Presse Médicale. 40(4). 420–426. 2 indexed citations
4.
Quoix, Élisabeth, et al.. (2008). Le cancer bronchique du sujet âgé. ONCOLOGIE. 10(9). 536–539.
5.
Chaouat, Ari, Nabila Kadaoui, Roland Schött, et al.. (2005). Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 172(2). 189–194. 454 indexed citations
6.
Chaouat, Ari, Matthieu Canuet, Nabila Kadaoui, et al.. (2005). Hypertension pulmonaire des affections respiratoires chroniques. La Presse Médicale. 34(19). 1465–1474. 4 indexed citations
7.
9.
Gervais, R., A Ducoloné, Jean-Luc Breton, et al.. (2004). Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Annals of Oncology. 16(1). 90–96. 104 indexed citations
10.
Quoix, Élisabeth, Jean-Luc Breton, A Ducoloné, et al.. (2004). First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule. Lung Cancer. 47(3). 405–412. 15 indexed citations
11.
Quoix, Élisabeth, B Lebeau, A Depierre, et al.. (2003). Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy fornon-small-cell lung cancer. Annals of Oncology. 15(1). 38–44. 36 indexed citations
12.
Gaugler, Marie‐Hélène, et al.. (2002). Rôle du reflux gastro-œsophagien dans l'asthme du nourrisson et du jeune enfant. Archives de Pédiatrie. 9. 396–401. 4 indexed citations
13.
Kessler, Romain, M Faller, E Weitzenblum, et al.. (2001). “Natural History” of Pulmonary Hypertension in a Series of 131 Patients with Chronic Obstructive Lung Disease. American Journal of Respiratory and Critical Care Medicine. 164(2). 219–224. 249 indexed citations
14.
Faller, M, Romain Kessler, Ari Chaouat, et al.. (1998). Regulation of Endothelin-1 at Rest and During a Short Steady-State Exercise in 21 COPD Patients. Pulmonary Pharmacology & Therapeutics. 11(2-3). 151–157. 14 indexed citations
15.
Bardet, É., Alain Rivière, Anne Charloux, et al.. (1997). A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: Final analysis. International Journal of Radiation Oncology*Biology*Physics. 38(1). 163–168. 8 indexed citations
16.
Bardet, É., Jean‐Yves Douillard, A. Riviére, et al.. (1996). 2139 Chemotherapy followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): First interim analysis of a phase II trial. International Journal of Radiation Oncology*Biology*Physics. 36(1). 345–346. 1 indexed citations
17.
Ducoloné, A, H. Jouin, Jean‐Jacques Grob, et al.. (1988). [Gastroesophageal reflux in asthmatic and chronic bronchitis patients].. PubMed. 20(6). 218–25. 3 indexed citations
18.
Ducoloné, A, et al.. (1984). Fibrose pulmonaire et spondylarthrite ankylosante.. Revue de Pneumologie Clinique. 40(2). 2 indexed citations
19.
Fraisse, Philippe, et al.. (1984). [Idiopathic progressive pleuropulmonary fibrosis. Apropos of 2 cases].. PubMed. 40(2). 139–43. 5 indexed citations
20.
Weitzenblum, E, et al.. (1981). Signification pronostique de l'hypertension artérielle pulmonaire dans les bronchopneumopathies chroniques obstructives.. 37(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026